Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial

by Pluschnig Ursula, Bartsch Rupert, Hubalek Michael, Mlineritsch Brigitte, Fiegl Michael, Steger Günther G
Published 2011-08-01